INKT
Mink Therapeutics Inc
NASDAQ: INKT · HEALTHCARE · BIOTECHNOLOGY
$11.81
+8.55% today
Updated 2026-04-29
Market cap
$55.32M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.93
Dividend yield
—
52W range
$6 – $76
Volume
0.4M
Mink Therapeutics Inc (INKT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-1,239.00%
ROA
-79.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $689626.00 | $-23.80M | 100.00% | -3,231.39% | -3,451.46% |
| 2020 | $0.00 | $-16.24M | — | — | — |
| 2021 | $0.00 | $-30.21M | — | — | — |
| 2022 | $2.70B | $-27.99M | -0.00% | -1.14% | -1.03% |
| 2023 | $0.00 | $-22.46M | — | — | — |
| 2024 | $0.00 | $-10.78M | — | — | — |
| 2025 | $0.00 | $-12.49M | — | — | — |